Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Pujol

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Journal of Thoracic Disease|June 17, 2026
SLFN11 expression as a marker of small cell lung cancer vulnerability to combined PARP inhibitors and immune checkpoint inhibitors during maintenanceJean-Louis Pujol
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2016
Is Weight Loss a Loss of Chance in Patients Receiving Chemoradiotherapy?Jean-Louis Pujol
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2022
Durvalumab Induces Sustained Survival Benefit After Concurrent Chemoradiotherapy in Stage III Non-Small-Cell Lung CancerJean-Louis Pujol
Lung Cancer (Amsterdam, Netherlands)|May 26, 2005
Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trialsFabrice Barlési, Jean-Louis Pujol
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2010
Time to diagnosis of lung cancer: technical and pyschological factors that slow down diagnostic and treatment timelinesJean Louis Pujol, Xavier Quantin
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2020
Is Darbepoietin Alfa Linked to Mortality During Non-Small Cell Lung Cancer Chemotherapy?Jean-Louis Pujol, Benoit Roch
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Staging metastasis profile of non-small cell lung cancer: a new paradigm?Jean Louis Pujol, Mohammad Chakra
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antisense oligonucleotides in lung cancerJean-Louis Pujol, William Jacot
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2018
Introduction to the Special Section: The Experience and Impact of Lung Cancer StigmaHeidi A Hamann, Jean-Louis Pujol
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 6, 2024
Familial Lung Cancers Caused by EGFR Germline Mutations: The Frequency Is Probably Underestimated but Specific Genotypic Features and Some Particular Disease Characteristics Should Help Their ScreeningJean Louis Pujol, Wilfried Ernst Erich Eberhardt
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Journal of Thoracic Disease|June 17, 2026
SLFN11 expression as a marker of small cell lung cancer vulnerability to combined PARP inhibitors and immune checkpoint inhibitors during maintenanceJean-Louis Pujol
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2016
Is Weight Loss a Loss of Chance in Patients Receiving Chemoradiotherapy?Jean-Louis Pujol
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2022
Durvalumab Induces Sustained Survival Benefit After Concurrent Chemoradiotherapy in Stage III Non-Small-Cell Lung CancerJean-Louis Pujol
Lung Cancer (Amsterdam, Netherlands)|May 26, 2005
Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trialsFabrice Barlési, Jean-Louis Pujol
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 4, 2010
Time to diagnosis of lung cancer: technical and pyschological factors that slow down diagnostic and treatment timelinesJean Louis Pujol, Xavier Quantin
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2020
Is Darbepoietin Alfa Linked to Mortality During Non-Small Cell Lung Cancer Chemotherapy?Jean-Louis Pujol, Benoit Roch
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Staging metastasis profile of non-small cell lung cancer: a new paradigm?Jean Louis Pujol, Mohammad Chakra
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antisense oligonucleotides in lung cancerJean-Louis Pujol, William Jacot
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2018
Introduction to the Special Section: The Experience and Impact of Lung Cancer StigmaHeidi A Hamann, Jean-Louis Pujol
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 6, 2024
Familial Lung Cancers Caused by EGFR Germline Mutations: The Frequency Is Probably Underestimated but Specific Genotypic Features and Some Particular Disease Characteristics Should Help Their ScreeningJean Louis Pujol, Wilfried Ernst Erich Eberhardt
Pageof 10